Can a Zinc-Based compound fight cancer?

NCT ID NCT06506643

Recruiting now Disease control Sponsor: Vector Vitale LLC Source: ClinicalTrials.gov ↗

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This trial tests an experimental drug called KLS-1, a form of zinc aspartate enriched with a specific zinc isotope, in adults with certain solid tumors (like melanoma, prostate, or pancreatic cancer) or chronic lymphocytic leukemia (CLL). The goal is to find the safest and most effective dose, understand how the drug behaves in the body, and see if it can shrink tumors or slow cancer growth. Participants receive KLS-1 through an IV every 21 days and are monitored for side effects and any signs of anti-tumor activity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: KLS-1, a solution of zinc aspartate enriched with the isotope zinc-64, given by intravenous infusion
What this could lead to: If KLS-1 proves safe and shows anti-tumor activity, it could become a new treatment option for certain advanced cancers and chronic lymphocytic leukemia.
What could go wrong: This is an early, small trial focused on safety and dosing, so it may not lead to an effective treatment. Potential side effects are not yet fully known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

B-cell chronic lymphocytic leukemia melanoma neoplasm Neoplasm Metastasis pancreatic neoplasm prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CLL SOLID TUMOR, ADULT

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Medical Centre of Arensia Exploratory Medicine LLC
RECRUITING

Kyiv, 01135, Ukraine
Medical and Diagnostic Center of Private Enterprise of Private Manufacturing Company "Acinus"
RECRUITING

Kropyvnytskyi, 25006, Ukraine

More trials for these conditions

Other studies related to the condition(s) this trial covers.